Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open label phase II study to assess induction chemotherapy using cisplatin and vinorelbine (navelbine) followed by concomitant chemo-irradiation for unresectable non-metastatic non-small cell lung cancer (Protocol PLY-DY0001)

Trial Profile

Open label phase II study to assess induction chemotherapy using cisplatin and vinorelbine (navelbine) followed by concomitant chemo-irradiation for unresectable non-metastatic non-small cell lung cancer (Protocol PLY-DY0001)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2005

At a glance

  • Drugs Antineoplastics; Cisplatin; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms DYLAN
  • Most Recent Events

    • 01 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top